U.S. Markets open in 1 hr 31 mins
  • S&P Futures

    3,853.25
    +8.25 (+0.21%)
     
  • Dow Futures

    31,155.00
    +59.00 (+0.19%)
     
  • Nasdaq Futures

    13,349.75
    +55.50 (+0.42%)
     
  • Russell 2000 Futures

    2,163.70
    +6.00 (+0.28%)
     
  • Crude Oil

    53.00
    -0.31 (-0.58%)
     
  • Gold

    1,872.00
    +5.50 (+0.29%)
     
  • Silver

    26.02
    +0.26 (+1.01%)
     
  • EUR/USD

    1.2149
    +0.0034 (+0.2794%)
     
  • 10-Yr Bond

    1.0900
    0.0000 (0.00%)
     
  • Vix

    21.28
    -1.96 (-8.43%)
     
  • GBP/USD

    1.3712
    +0.0057 (+0.4169%)
     
  • USD/JPY

    103.4400
    -0.1300 (-0.1255%)
     
  • BTC-USD

    32,632.75
    -869.34 (-2.59%)
     
  • CMC Crypto 200

    647.36
    -32.55 (-4.79%)
     
  • FTSE 100

    6,747.50
    +7.11 (+0.11%)
     
  • Nikkei 225

    28,756.86
    +233.60 (+0.82%)
     

Moderna Inc (MRNA) CEO Stephane Bancel Sold $2.6 million of Shares

GuruFocus.com
·2 min read

- By insider

CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 19,000 shares of MRNA on 12/17/2020 at an average price of $137.77 a share. The total sale was $2.6 million.


Moderna Inc has a market cap of $55.49 billion; its shares were traded at around $140.230000 with and P/S ratio of 219.12. GuruFocus has detected 5 severe warning signs with Moderna Inc. .

CEO Recent Trades:

  • CEO Stephane Bancel sold 19,000 shares of MRNA stock on 12/17/2020 at the average price of $137.77. The price of the stock has increased by 1.79% since.

  • CEO Stephane Bancel sold 11,046 shares of MRNA stock on 12/11/2020 at the average price of $159.18. The price of the stock has decreased by 11.9% since.

  • CEO Stephane Bancel sold 22,832 shares of MRNA stock on 12/10/2020 at the average price of $158.07. The price of the stock has decreased by 11.29% since.

  • CEO Stephane Bancel sold 21,046 shares of MRNA stock on 12/04/2020 at the average price of $148.11. The price of the stock has decreased by 5.32% since.

  • CEO Stephane Bancel sold 12,929 shares of MRNA stock on 12/02/2020 at the average price of $150.55. The price of the stock has decreased by 6.85% since.

Directors and Officers Recent Trades:

  • President Stephen Hoge sold 20,000 shares of MRNA stock on 12/14/2020 at the average price of $163.63. The price of the stock has decreased by 14.3% since.

  • Chief Medical Officer Tal Zvi Zaks sold 25,034 shares of MRNA stock on 12/14/2020 at the average price of $157.81. The price of the stock has decreased by 11.14% since.

  • Chief Medical Officer Tal Zvi Zaks sold 20,000 shares of MRNA stock on 12/07/2020 at the average price of $158.47. The price of the stock has decreased by 11.51% since.

  • President Stephen Hoge sold 20,000 shares of MRNA stock on 12/03/2020 at the average price of $141.08. The price of the stock has decreased by 0.6% since.

  • Chief Medical Officer Tal Zvi Zaks sold 20,000 shares of MRNA stock on 11/30/2020 at the average price of $147.76. The price of the stock has decreased by 5.1% since.

For the complete insider trading history of MRNA, click here

.This article first appeared on GuruFocus.